Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Total Non-Current Liabilities came in at $9.4 billion in Q1 2026, down 2.42% year-on-year from $9.6 billion in Q1 2025, and down 3.59% quarter-over-quarter from $9.8 billion in Q4 2025.
Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $9.4 billion for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 2.42% year-over-year to $9.4 billion in Q1 2026; TTM through Mar 2026 was $9.4 billion, a 2.42% decrease from a year earlier, with the FY2025 full-year figure at $9.8 billion, up 12.07% from the prior year.
- Total Non-Current Liabilities declined to $9.4 billion in Q1 2026 per ZBH's latest filing, from $9.8 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $9.9 billion in Q3 2025 and bottomed at $7.6 billion in Q2 2024.
- The 5-year median for Total Non-Current Liabilities is $8.6 billion (2024), against an average of $8.8 billion.
- Across the five-year window, Total Non-Current Liabilities slipped 20.99% in 2022 and advanced 24.94% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $8.4 billion in 2022, then declined by 3.85% to $8.1 billion in 2023, then grew by 7.74% to $8.7 billion in 2024, then grew by 12.07% to $9.8 billion in 2025, then declined by 3.59% to $9.4 billion in 2026.
- Per Business Quant, the three latest ZBH Total Non-Current Liabilities figures stand at $9.4 billion (Q1 2026), $9.8 billion (Q4 2025), and $9.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn | 9.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.41 Bn |
| Dec 31, 2025 | 9.76 Bn |
| Sep 30, 2025 | 9.92 Bn |
| Jun 30, 2025 | 9.45 Bn |
| Mar 31, 2025 | 9.64 Bn |
| Dec 31, 2024 | 8.71 Bn |
| Sep 30, 2024 | 8.31 Bn |
| Jun 30, 2024 | 7.57 Bn |
| Mar 31, 2024 | 8.57 Bn |
| Dec 31, 2023 | 8.08 Bn |
| Sep 30, 2023 | 8.30 Bn |
| Jun 30, 2023 | 8.27 Bn |
| Mar 31, 2023 | 8.45 Bn |
| Dec 31, 2022 | 8.41 Bn |
| Sep 30, 2022 | 8.47 Bn |
| Jun 30, 2022 | 8.74 Bn |
| Mar 31, 2022 | 9.04 Bn |
| Dec 31, 2021 | 10.24 Bn |
| Sep 30, 2021 | 10.70 Bn |
| Jun 30, 2021 | 11.06 Bn |